1.68
price down icon1.18%   -0.02
after-market 시간 외 거래: 1.71 0.03 +1.79%
loading
전일 마감가:
$1.70
열려 있는:
$1.72
하루 거래량:
840.66K
Relative Volume:
0.96
시가총액:
$181.91M
수익:
$27.08M
순이익/손실:
$-37.00M
주가수익비율:
-3.2308
EPS:
-0.52
순현금흐름:
$-18.46M
1주 성능:
+2.44%
1개월 성능:
+14.29%
6개월 성능:
-29.71%
1년 성능:
+20.86%
1일 변동 폭
Value
$1.64
$1.76
1주일 범위
Value
$1.62
$1.78
52주 변동 폭
Value
$1.05
$5.17

Aclaris Therapeutics Inc Stock (ACRS) Company Profile

Name
명칭
Aclaris Therapeutics Inc
Name
전화
484-324-7933
Name
주소
701 LEE ROAD, WAYNE, PA
Name
직원
64
Name
트위터
@aclaristx
Name
다음 수익 날짜
2025-02-24
Name
최신 SEC 제출 서류
Name
ACRS's Discussions on Twitter

ACRS을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
ACRS
Aclaris Therapeutics Inc
1.68 184.08M 27.08M -37.00M -18.46M -0.52
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
460.83 120.60B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.63 60.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
324.79 42.87B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
595.19 36.23B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.51 31.54B 3.81B -644.79M -669.77M -6.24

Aclaris Therapeutics Inc Stock (ACRS) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-07-10 재개 Piper Sandler Overweight
2025-05-28 개시 Wedbush Outperform
2025-03-18 재개 Cantor Fitzgerald Overweight
2024-12-23 업그레이드 H.C. Wainwright Neutral → Buy
2024-11-20 업그레이드 Cantor Fitzgerald Neutral → Overweight
2024-11-19 업그레이드 BTIG Research Neutral → Buy
2024-11-19 업그레이드 Jefferies Hold → Buy
2024-11-19 업그레이드 Leerink Partners Market Perform → Outperform
2024-11-18 업그레이드 Piper Sandler Neutral → Overweight
2024-01-22 다운그레이드 H.C. Wainwright Buy → Neutral
2023-11-13 다운그레이드 William Blair Outperform → Mkt Perform
2023-10-03 개시 Evercore ISI Outperform
2022-12-14 개시 Stifel Buy
2022-12-01 개시 Goldman Buy
2022-10-06 개시 BTIG Research Buy
2021-07-23 재개 Jefferies Buy
2021-06-15 개시 Piper Sandler Overweight
2021-04-21 개시 H.C. Wainwright Buy
2019-10-22 업그레이드 SVB Leerink Mkt Perform → Outperform
2019-09-06 다운그레이드 JMP Securities Mkt Outperform → Mkt Perform
2019-06-27 다운그레이드 SVB Leerink Outperform → Mkt Perform
2019-05-06 개시 SVB Leerink Outperform
2018-03-28 재개 Leerink Partners Outperform
2018-02-09 개시 Guggenheim Buy
2017-06-16 개시 Cantor Fitzgerald Overweight
2016-11-29 개시 Leerink Partners Outperform
2016-09-30 개시 JMP Securities Mkt Outperform
2016-06-10 개시 Guggenheim Buy
2015-11-02 개시 Citigroup Buy
2015-11-02 개시 Jefferies Buy
모두보기

Aclaris Therapeutics Inc 주식(ACRS)의 최신 뉴스

pulisher
03:51 AM

Biopharma firm with big St. Louis operations names new chief scientific officer - The Business Journals

03:51 AM
pulisher
08:47 AM

Aclaris Therapeutics Announces Leadership Transition - GlobeNewswire

08:47 AM
pulisher
08:45 AM

Aclaris Appoints Drug Development Veteran Behind 6 FDA-Approved Antibodies as New CSO - Stock Titan

08:45 AM
pulisher
08:17 AM

Momentum divergence signals in Aclaris Therapeutics Inc. chartTrend Following Ideas with Volume Confirmation - Newser

08:17 AM
pulisher
06:27 AM

Market reaction to Aclaris Therapeutics Inc.’s recent newsFree Expert Verified Stock Trade Ideas - Newser

06:27 AM
pulisher
04:50 AM

Using R and stats models for Aclaris Therapeutics Inc. forecasting Free Smart Trend Trading with Weekly Signals - Newser

04:50 AM
pulisher
04:38 AM

What is the risk reward ratio of investing in Aclaris Therapeutics Inc. stockHigh-performance stocks for savvy investors - jammulinksnews.com

04:38 AM
pulisher
12:25 PM

What are Aclaris Therapeutics Inc. company’s key revenue driversMaximize returns with effective portfolio management - jammulinksnews.com

12:25 PM
pulisher
Jul 27, 2025

What are analysts’ price targets for Aclaris Therapeutics Inc. in the next 12 monthsHarness the power of proven investment plans - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What are the latest earnings results for Aclaris Therapeutics Inc.Capitalize on emerging growth stocks - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Published on: 2025-07-28 01:01:49 - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How Resilient Is Aclaris Therapeutics Inc. Stock During Economic DownturnsLong Term Secure Gain Stocks - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

Published on: 2025-07-27 19:20:18 - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How Efficient Is Aclaris Therapeutics Inc. at Controlling Operating CostsInsider Level Guidance - Newser

Jul 27, 2025
pulisher
Jul 25, 2025

What drives Aclaris Therapeutics Inc. stock priceRapidly expanding wealth - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Aclaris Therapeutics Inc. Stock Analysis and ForecastConsistently high returns - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What institutions are buying Aclaris Therapeutics Inc. stock nowPhenomenal returns - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about Aclaris Therapeutics Inc. stockFree Predictions - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Why Aclaris Therapeutics Inc. stock attracts strong analyst attentionFree Professional Portfolio Management - Newser

Jul 25, 2025
pulisher
Jul 23, 2025

LENZ Therapeutics Inc. Stock Analysis and ForecastPhenomenal capital appreciation - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Is Aclaris Therapeutics Inc. a good long term investmentRapid capital growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

How Aclaris Therapeutics Inc. stock performs during market volatilityDaily Volume Leaders - Newser

Jul 22, 2025
pulisher
Jul 15, 2025

What makes Aclaris Therapeutics Inc. stock price move sharplyEntry Level Low Risk Picks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Aclaris Therapeutics Begins Phase 1 Clinical Trial for Bispecific Antibody ATI-052 Targeting Inflammatory Diseases - Insider Monkey

Jul 15, 2025
pulisher
Jul 15, 2025

13 Best Low Priced Pharma Stocks to Buy Now - Insider Monkey

Jul 15, 2025
pulisher
Jul 12, 2025

Piper Sandler Begins Coverage on Aclaris Therapeutics (NASDAQ:ACRS) - Defense World

Jul 12, 2025
pulisher
Jul 11, 2025

Aclaris Therapeutics' Recent Gains Improve Losses On Insider Purchases Worth US$1.50m - simplywall.st

Jul 11, 2025
pulisher
Jul 10, 2025

Plus Therapeutics (NASDAQ:PSTV) vs. Aclaris Therapeutics (NASDAQ:ACRS) Head-To-Head Survey - Defense World

Jul 10, 2025
pulisher
Jul 07, 2025

Aclaris Therapeutics Joins Russell 3000 and Russell 2000 Indexes - MSN

Jul 07, 2025
pulisher
Jul 07, 2025

Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Receives Consensus Rating of “Buy” from Brokerages - Defense World

Jul 07, 2025

Aclaris Therapeutics Inc (ACRS) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$23.09
price down icon 1.32%
$37.06
price up icon 1.06%
$101.75
price down icon 2.12%
$27.45
price down icon 4.26%
$112.79
price down icon 2.19%
biotechnology ONC
$294.51
price up icon 1.04%
자본화:     |  볼륨(24시간):